SL
GILD icon

Salomon & Ludwin’s Gilead Sciences GILD Stock Holding History

Salomon & Ludwin’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81K Sell
643
-17
-3% -$2.24K 0.01% 333
2026
Q1 		$92.2K Hold
660
– – 0.01% 268
2025
Q4 		$78.1K Buy
660
+178
+37% +$21.6K 0.01% 287
2025
Q3 		$54.3K Buy
482
+282
+141% +$32.1K ﹤0.01% 364
2025
Q2 		$22.3K Buy
+200
New +$21.3K ﹤0.01% 371
2024
Q4 		– Sell
-18
Closed -$1.51K – 732
2024
Q3 		$1.51K Hold
18
– – ﹤0.01% 634
2024
Q2 		$1.24K Sell
18
-1,375
-99% -$91.8K ﹤0.01% 646
2024
Q1 		$100K Sell
1,393
-100
-7% -$7.69K 0.01% 256
2023
Q4 		$112K Hold
1,493
– – 0.01% 212
2023
Q3 		$112K Buy
+1,493
New +$115K 0.01% 212
2019
Q2 		– Sell
-18
Closed -$1K – 235
2019
Q1 		$1K Buy
+18
New +$1.2K ﹤0.01% 237

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Salomon & Ludwin's GILD Position: Q2 2026 in Review

Salomon & Ludwin reduced its Gilead Sciences (GILD) stake by 2.6% in Q2 2026, selling an estimated $2.24K and leaving 643 shares worth $81K. The position accounts for 0.01% of the portfolio, ranked #333.

Salomon & Ludwin first reported a position in GILD in Q1 2019 and has held it in 11 quarters since. The position peaked at $112K in Q4 2023. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Salomon & Ludwin held 643 shares of Gilead Sciences worth $81K as of Q2 2026.
  • Salomon & Ludwin sold 17 Gilead Sciences shares in Q2 2026, an estimated $2.24K.
  • Gilead Sciences made up 0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #333 holding.
  • Salomon & Ludwin first reported a position in Gilead Sciences in Q1 2019 and has held it in 11 quarters since.
  • Salomon & Ludwin's Gilead Sciences position peaked at $112K in Q4 2023.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.